The Arizona spinout plans to develop a biopsy needle that could improve the chances of identifying precision treatments for cancer.

University of Arizona spun out US-based oncological services spinout called Data Driven Diagnostics Services (D3Sciences) on Tuesday to commercialise a needle instrument that could increase the quantities of human tissue collected during biopsies.

The tool is designed to collect material from outside the needle, potentially amassing seven times as much tissue as conventional instruments.

Better samples from oncological biopsies could improve pathological testing and facilitate the prescription of genetic and molecular-based therapies rather than conventional chemotherapy, which risks severe side…